Table 2.
Age-Adjusted Rates of Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by Age and Race/Ethnicity, 2012–2015
| RR (95% CI) | RR (95% CI) | RR (95% CI) | ||||
|---|---|---|---|---|---|---|
|
Incidence Race/Ethnicity | ||||||
| NH White | 11.87 (11.75, 11.98) | Reference | 360.06 (358.74, 361.38) | Reference | 449.82 (447.78, 451.86) | Reference |
| NH Black | 27.66 (27.24, 28.08)* | 2.33 (2.29, 2.37) | 674.07 (669.04, 679.13)* | 1.87 (1.86, 1.89) | 684.96 (676.82, 693.17)* | 1.52 (1.50, 1.54) |
| Hispanic | 8.00 (7.80, 8.21)* | 0.67 (0.66, 0.69) | 306.03 (302.44, 309.65)* | 0.85 (0.84, 0.86) | 457.90 (451.03, 464.86) | 1.02 (1.00, 1.03) |
| NH API | 3.87 (3.64, 4.11)* | 0.33 (0.31, 0.35) | 181.07 (177.19, 185.01)* | 0.50 (0.49, 0.51) | 294.52 (287.22, 301.96)* | 0.66 (0.64, 0.67) |
| NH AIAN | 8.79 (7.90, 9.75)* | 0.74 (0.67, 0.82) | 242.25 (230.92, 253.98)* | 0.67 (0.64, 0.71) | 358.95 (336.09, 383.01)* | 0.80 (0.75, 0.85) |
| Distant stage | ||||||
| NH White | 0.44 (0.42, 0.47) | Reference | 13.91 (13.65, 14.17) | Reference | 49.32 (48.64, 50.00) | Reference |
| NH Black | 1.32 (1.23, 1.41)* | 2.97 (2.73, 3.24) | 40.55 (39.32, 41.80)* | 2.91 (2.81, 3.02) | 90.36 (87.30, 93.50)* | 1.83 (1.77, 1.90) |
| Hispanic | 0.49 (0.44, 0.54) | 1.10 (0.98, 1.24) | 17.26 (16.42, 18.13)* | 1.24 (1.18, 1.31) | 52.26 (49.90, 54.70) | 1.06 (1.01, 1.11) |
| NH API | 0.19 (0.14, 0.25)* | 0.42 (0.31, 0.56) | 9.65 (8.77, 10.60)* | 0.69 (0.63, 0.76) | 34.89 (32.34, 37.59)* | 0.71 (0.65, 0.76) |
| NH AIAN | 0.73 (0.49, 1.03) | 1.64 (1.11, 2.34) | 16.84 (13.95, 20.15) | 1.21 (1.00, 1.45) | 53.51 (44.44, 63.88) | 1.08 (0.90, 1.30) |
| Mortality | ||||||
| NH White | 0.31 (0.29, 0.33) | Reference | 17.79 (17.49, 18.08) | Reference | 169.15 (167.89, 170.42) | Reference |
| NH Black | 0.81 (0.74, 0.89)* | 2.62 (2.35, 2.91) | 49.93 (48.55, 51.35)* | 2.81 (2.72, 2.90) | 360.30 (354.00, 366.68)* | 2.13 (2.09, 2.17) |
| Hispanic | 0.25 (0.22, 0.29) | 0.80 (0.69, 0.94) | 16.35 (15.52, 17.21)* | 0.92 (0.87, 0.97) | 149.09 (145.02, 153.24)* | 0.88 (0.86, 0.91) |
| NH API | 0.11 (0.07, 0.15)* | 0.34 (0.23, 0.50) | 7.34 (6.58, 8.18)* | 0.41 (0.37, 0.46) | 83.75 (79.67, 87.98)* | 0.50 (0.47, 0.52) |
| NH AIAN | ** | ** | 19.84 (16.69, 23.41) | 1.12 (0.94, 1.32) | 166.59 (149.86, 184.66) | 0.99 (0.89, 1.09) |
NH = Non-Hispanic; API = Asian/Pacific Islander; AIAN = American Indian/Alaska Native
Rates are per 100,000 men and are age-adjusted to the 2000 U.S. standard population (19 age groups – Census P25–1130).
Asterisk(*) indicates statistically significant difference (P < 0.05) from Non-Hispanic white estimate.
Double asterisk (**) indicates suppressed due to low counts
Data are from population-based registries that participate in CDC’s National Program of Cancer Registries and/or NCI’s Surveillance, Epidemiology, and End Results Program and meet high-quality data criteria. These registries cover 100% of the U.S. population for 2012 to 2015.
National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: NPCR and SEER Incidence – U.S. Cancer Statistics Public Use Research Database, Nov 2017 submission (2001–2015), United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Released June 2018, based on November 2017 submissions. Available at www.cdc.gov/cancer/public-use.